Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

RTTNews | 955 dni temu
Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

(RTTNews) - Incyte Corp. (INCY) announced Friday that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor, for once-daily (QD) use in the treatment of certain types of myelofibrosis (MF), polycythemia vera (PV) and graft-versus-host disease (GVHD).

The complete response letter states that the FDA cannot approve the application in its present form. The FDA acknowledged that the study submitted in the New Drug Application (NDA) met its objective of bioequivalence based on area under the curve (AUC) parameters but identified additional requirements for approval.

Incyte intends to meet with the FDA to determine appropriate next steps.

The NDA was based on two studies designed to show that ruxolitinib XR tablets are dosage strength proportional and bioequivalent to Jakafi (ruxolitinib) tablets.

read more
Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Corp. (INCY) on Tuesday reported net income of $201.10 million or $0.89 per share for the fourth quarter, sharply higher than $28.46 million or $0.13 per share in the prior-year quarter.
RTTNews | 629 dni temu
Incyte Q1 Results Top Estimates

Incyte Q1 Results Top Estimates

Incyte Corp. (INCY) on Tuesday reported net income of $161.43 million or $0.72 per share for the first quarter, up from $149.46 million or $0.67 per share in the prior-year quarter.
RTTNews | 1189 dni temu
Bay Street Likely To Open On Positive Note

Bay Street Likely To Open On Positive Note

Canadian shares are likely to open higher Monday morning, with firm metal prices expected to trigger buying in the materials sector. The focus will be on the developments on the trade front and corporate earnings announcements.
RTTNews | 2g 36 minut temu
UK Manufacturing PMI At 1-Year High

UK Manufacturing PMI At 1-Year High

The UK manufacturing activity shrank in October but the pace of contraction was the slowest in a year, the final purchasing managers' survey from S&P Global revealed on Monday. The factory Purchasing Managers' Index rose to a 12-month high of 49.7 in October from 46.2 in September. The flash reading was 49.6.
RTTNews | 3g 9 minut temu
Eurozone Manufacturing Sector Stagnates In October

Eurozone Manufacturing Sector Stagnates In October

Eurozone manufacturing sector stagnated in October, as initially estimated, following a fractional deterioration in September, the purchasing managers' survey compiled by S&P Global showed on Monday. The final Purchasing Managers' Index posted 50.0 in October, signalling no change in the operating conditions in the manufacturing sector. The score matched the initial estimate and remained above S
RTTNews | 3g 41 minut temu
FTSE 100 Up Marginally In Cautious Trade

FTSE 100 Up Marginally In Cautious Trade

U.K.'s stock market's FTSE 100 is gaining some ground in positive territory on Monday, with stocks from the banking sector attracting attention ahead of the Bank of England's monetary policy announcement this week.
RTTNews | 3g 59 minut temu
Fed's Hawkish Guidance Lifts Dollar

Fed's Hawkish Guidance Lifts Dollar

A drastic reduction in Fed rate cut hopes in the aftermath of the hawkish forward guidance by Chair Jerome Powell boosted the U.S. Dollar during the week ended October 31.
RTTNews | 4g 10 minut temu